- Management of viral hepatitis in liver transplant recipients
-
Jeong SW, Choi Y, Kim JW
- KMID: 2070250
- Clin Mol Hepatol.
- 2014 Dec;20(4):338-344.
- doi: 10.3350/cmh.2014.20.4.338
Recurrence of viral hepatitis after liver transplantation (LT) can progress to graft failure and lead to a decrease in long-term survival. Recently, there have been remarkable improvement in the treatment... -
- CITED
-
- Close
- SHARE
-
- Close
- Oromucosal Cytokine Therapy: Mechanism(s) of Action
-
Tovey MG
- KMID: 1123161
- Korean J Hepatol.
- 2002 Jun;8(2):125-131.
Oromucosal cytokine therapy allows large amounts of cytokines to be administered with improved outcome and without dose limiting toxicity. Orally administered cytokines exert their effects by a novel two pronged... -
- CITED
-
- Close
- SHARE
-
- Close
- Prediction of fibrosis progression in chronic viral hepatitis
-
Wong GL
- KMID: 2069758
- Clin Mol Hepatol.
- 2014 Sep;20(3):228-236.
- doi: 10.3350/cmh.2014.20.3.228
Prediction of liver fibrosis progression has a key role in the management of chronic viral hepatitis, as it will be translated into the future risk of cirrhosis and its various... -
- CITED
-
- Close
- SHARE
-
- Close
